Geoffrey Gilmore - Agile Thrpe Senior Officer
| AGRXDelisted Stock | USD 2.94 0.08 2.65% |
Executive
Geoffrey Gilmore is Senior Officer of Agile Thrpe
| Age | 58 |
| Phone | 609 683 1880 |
| Web | https://www.agiletherapeutics.com |
Agile Thrpe Management Efficiency
The company has return on total asset (ROA) of (0.9671) % which means that it has lost $0.9671 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.6404) %, meaning that it created substantial loss on money invested by shareholders. Agile Thrpe's management efficiency ratios could be used to measure how well Agile Thrpe manages its routine affairs as well as how well it operates its assets and liabilities.Agile Thrpe currently holds 2.21 M in liabilities with Debt to Equity (D/E) ratio of 3.95, implying the company greatly relies on financing operations through barrowing. Agile Thrpe has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Agile Thrpe's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kenneth Marshall | Aquestive Therapeutics | 65 | |
| Marilyn Carlson | Evoke Pharma | 76 | |
| Jackie Klecker | Lifecore Biomedical | N/A | |
| Gene Esq | Shuttle Pharmaceuticals | N/A | |
| Darren Hieber | Lifecore Biomedical | N/A | |
| Erin Gull | Cumberland Pharmaceuticals | N/A | |
| Damon JD | Alpha Teknova | 54 | |
| Karen FFPM | Cyclo Therapeutics | N/A | |
| Cassie Jung | Aquestive Therapeutics | 45 | |
| Ernest Toth | Aquestive Therapeutics | 65 | |
| Jennifer Henry | Alpha Teknova | N/A | |
| Timothy CPA | Shuttle Pharmaceuticals | 66 | |
| John Shulman | Petros Pharmaceuticals | 61 | |
| Robert Arnold | Aquestive Therapeutics | N/A | |
| Carl MD | Aquestive Therapeutics | 54 | |
| Gregory Sgammato | Amneal Pharmaceuticals, Class | N/A | |
| Michael Lisjak | Cyclo Therapeutics | 50 | |
| Paul Schwichtenberg | Assertio Therapeutics | 53 | |
| Lori McKenna | Cyclo Therapeutics | N/A | |
| Pranav Mehta | Amneal Pharmaceuticals, Class | ||
| MD MBA | Assertio Therapeutics | N/A | |
Management Performance
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 |
Agile Thrpe Leadership Team
Elected by the shareholders, the Agile Thrpe's board of directors comprises two types of representatives: Agile Thrpe inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agile. The board's role is to monitor Agile Thrpe's management team and ensure that shareholders' interests are well served. Agile Thrpe's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agile Thrpe's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD MBA, Senior Officer | ||
| Jason Butch, VP Officer | ||
| Joseph DUrso, Controller | ||
| Robert ME, Senior Officer | ||
| Kathryn PharmD, Advisor | ||
| Alfred Altomari, CEO and President and Director | ||
| Matthew Riley, Head Communications | ||
| Amy Welsh, Senior Officer | ||
| Geoffrey Gilmore, Senior Officer | ||
| Scott Coiante, CFO and VP | ||
| MPH MD, Consultant |
Agile Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agile Thrpe a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 633.86 K | |||
| Shares Outstanding | 2.96 M | |||
| Shares Owned By Insiders | 1.13 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Number Of Shares Shorted | 222.1 K | |||
| Price To Earning | (4.74) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Agile Stock
If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |